FDA Renews Canalevia-CA1 for Chemotherapy Induced Diarrhea in Dogs Through 2026
Clay Palmer Clay Palmer

FDA Renews Canalevia-CA1 for Chemotherapy Induced Diarrhea in Dogs Through 2026

Chemotherapy can be life saving for canine cancer patients, but anyone who has managed a dog with chemotherapy induced diarrhea knows how quickly GI side effects can derail treatment plans, stress pet parents, and drain clinic morale. That is why Jaguar Health’s latest news is worth your attention. The FDA has officially renewed the conditional approval of Canalevia-CA1, extending access to this targeted therapy for chemotherapy induced diarrhea in dogs through December 21, 2026.

Read More
Five Steers, One Skunk, and a $35,000 Wake Up Call: What a Minnesota Rabies Cluster Means for Cattle Vets
Clay Palmer Clay Palmer

Five Steers, One Skunk, and a $35,000 Wake Up Call: What a Minnesota Rabies Cluster Means for Cattle Vets

Rabies is often framed as a wildlife or small animal concern, but a 2024 outbreak on a Minnesota dairy farm is a reminder that production animal veterinarians are very much on the front lines. During a four week period in May, five steers on a single dairy farm developed neurologic disease consistent with rabies. What followed was a complex response involving euthanasia, quarantine, vaccination, human postexposure prophylaxis, and significant economic loss.

Read More
The Diseases That Could Break the Food System: 5 Livestock Threats Every Vet Needs to Know
Clay Palmer Clay Palmer

The Diseases That Could Break the Food System: 5 Livestock Threats Every Vet Needs to Know

Production animal disease outbreaks are no longer just herd health problems. They are economic shockwaves that can ripple through trade, food prices, and consumer confidence. According to a new Farm Journal Foundation report titled The Mean Sixteen: Biosecurity Threats Facing U.S. Agriculture, the top five livestock diseases alone could collectively cost U.S. agriculture more than $300 billion annually without adequate preparedness.

Read More
Palliative Chemotherapy Shows Promise for Feline Carcinoma of Unknown Primary
Clay Palmer Clay Palmer

Palliative Chemotherapy Shows Promise for Feline Carcinoma of Unknown Primary

Carcinoma of unknown primary, or CUP, is one of those diagnoses that makes even seasoned veterinary professionals pause. Despite advanced imaging, histopathology, and immunohistochemistry, the original tumor site remains elusive. In human oncology, CUP is relatively common and notoriously challenging, accounting for a notable percentage of new cancer diagnoses and carrying a guarded prognosis. In veterinary medicine, especially in cats, documented cases are few, leaving clinicians with limited guidance and a lot of tough conversations.

Read More